Gasoglen DSR Capsule contains a combination of Domperidone 30mg and Esomeprazole 40mg, formulated to manage gastrointestinal disorders characterized by acid reflux, heartburn, and delayed gastric emptying. Domperidone is a peripheral dopamine D2 receptor antagonist that enhances gastrointestinal motility by increasing the movement of the stomach and intestines, thereby facilitating gastric emptying and reducing symptoms such as nausea and vomiting. Esomeprazole, a proton pump inhibitor, suppresses gastric acid secretion by irreversibly inhibiting the H+/K+ ATPase enzyme system in the gastric parietal cells, providing effective relief from acid-related conditions such as gastroesophageal reflux disease (GERD), erosive esophagitis, and peptic ulcers. The synergistic action of Domperidone and Esomeprazole in Gasoglen DSR Capsule offers comprehensive management of upper gastrointestinal symptoms by addressing both motility and acid secretion abnormalities. This combination is indicated for patients experiencing symptomatic relief from acid reflux, dyspepsia, and gastroparesis. Gasoglen DSR should be used under medical supervision, with dosage adjustments based on clinical response and tolerability. Caution is advised in patients with cardiac disorders or electrolyte imbalances due to Domperidone’s potential to prolong the QT interval.